19951011
 Gensia Inc.   The Wall Street Journal,  Oct 12, 1995  Gensia Inc said it would receive $50 million from Upjohn Co in exchange for future marketing rights to certain cancer drugs that were part of a 1993 marketing and manufacturing agreement between the two companies. The revisions are subject to approval by Upjohn's board.   
